Compartment-specific gene regulation of the CAR inducer efavirenz in vivo.

Clinical Pharmacology and Therapeutics
H E Meyer zu SchwabedissenW Siegmund

Abstract

Nuclear receptors such as the constitutive androstane receptor (CAR) are central factors that link drug exposure to the activities of drug metabolism and elimination. In order to determine the in vivo effects of efavirenz, a CAR activator, the expression of target genes was determined in duodenal biopsies obtained from 12 healthy volunteers before treatment and after 10 days of treatment with efavirenz; concomitant administration of the cholesterol inhibitor ezetimibe produced no significant difference. However, in in vitro studies, efavirenz significantly increased CYP2B6 expression in several cell types, suggesting that the drug transactivates CAR. This hypothesis is supported by our findings that there is significant induction of CAR target genes in in vivo peripheral blood mononuclear cells (PBMCs) isolated from healthy volunteers treated with multiple doses of efavirenz. The impact of efavirenz on hepatic metabolism in vivo was confirmed by significant changes in plasma 4β-hydroxycholesterol and bilirubin levels and the area under the curve (AUC) of efavirenz. Induction of CYP2B6 mRNA expression correlated with the decrease in the AUC of efavirenz (r = 0.61; P = 0.036). Taken together, our results provide evidence that efa...Continue Reading

References

Jan 1, 1991·Critical Reviews in Clinical Laboratory Sciences·B T Doumas, T W Wu
Feb 26, 1999·The Journal of Biological Chemistry·T SueyoshiM Negishi
Jun 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·L B MooreS A Kliewer
Mar 30, 2001·The Journal of Biological Chemistry·D SmirlisE A Shephard
Apr 12, 2001·The Journal of Biological Chemistry·A GeickO Burk
May 9, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J SugataniT Sueyoshi
Oct 27, 2001·The Journal of Biological Chemistry·Sabine Gerbal-ChaloinPatrick Maurel
Dec 12, 2001·Clinical Pharmacokinetics·P F SmithG D Morse
Aug 2, 2002·Clinical Pharmacology and Therapeutics·Stéphane MoulyPaul B Watkins
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Junichiro SonodaRonald M Evans
Jun 12, 2003·Nucleic Acids Research·Scott S AuerbachCurtis J Omiecinski
Dec 17, 2003·Clinical Pharmacokinetics·Hongbing Wang, Edward L LeCluyse
Feb 24, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Dione Gardner-StephenAnna Radominska-Pandya
Jun 15, 2004·The Journal of Pharmacology and Experimental Therapeutics·Jatinder K LambaErin Schuetz
Jul 28, 2004·Trends in Pharmacological Sciences·Bryan Goodwin, John T Moore
Apr 2, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kaoru KobayashiKan Chiba
Jun 28, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·John G GerberUNKNOWN AIDS Clinical Trials Group A5108 Team
Sep 6, 2005·The Journal of Antimicrobial Chemotherapy·Lisa M AlmondDavid J Back
Oct 17, 2006·The Journal of Pharmacology and Experimental Therapeutics·Stephanie R FaucetteHongbing Wang
Oct 18, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gérard SiestSophie Visvikis-Siest
Nov 13, 2007·The Journal of Pharmacology and Experimental Therapeutics·Yazen Alnouti, Curtis D Klaassen
Jun 13, 2008·Nature Protocols·Thomas D Schmittgen, Kenneth J Livak
Feb 24, 2009·Journal of Pharmacological Sciences·Johanna WeissWalter Emil Haefeli
Dec 4, 2009·International Journal of Clinical Pharmacology and Therapeutics·D LütjohannU Diczfalusy
May 22, 2010·International Journal of Pharmaceutics·S ManceauJ M Tréluyer
Oct 1, 2010·Clinical Pharmacology and Therapeutics·E NgaimisiE Aklillu
Jul 1, 2011·The Journal of Antimicrobial Chemotherapy·Christoph WyenUNKNOWN German Competence Network for HIV/AIDS Coordinators

❮ Previous
Next ❯

Citations

May 17, 2015·Expert Opinion on Drug Metabolism & Toxicology·Milu T CherianTaosheng Chen
Mar 17, 2017·Inflammatory Bowel Diseases·Aze WilsonRichard B Kim
Sep 8, 2016·Antimicrobial Agents and Chemotherapy·Zeruesenay DestaRaymond E Galinsky
Aug 2, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sarah J WoolseyMelanie D Beaton
Feb 7, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Linda Björkhem-BergmanUlf Diczfalusy
Jun 24, 2017·Current Protocols in Pharmacology·Beatrice KisserMarkus Keiser
Nov 20, 2019·British Journal of Pharmacology·Simon NicolussiHenriette E Meyer Zu Schwabedissen
Oct 27, 2016·Biological Chemistry·Janett MüllerStefan Oswald
Dec 24, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David M StresserSarah S Wilson
Oct 29, 2020·Archives of Toxicology·Jukka HakkolaOlavi Pelkonen
Apr 7, 2021·Drug Metabolism Reviews·Laura E RussellVolker M Lauschke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Toxicological Sciences : an Official Journal of the Society of Toxicology
Joshua G DeKeyserCurtis J Omiecinski
Toxicology in Vitro : an International Journal Published in Association with BIBRA
Katie B PaulKevin M Crofton
© 2021 Meta ULC. All rights reserved